Literature DB >> 15557083

Extensive lesions of monkeypox in a prairie dog (Cynomys sp).

I M Langohr1, G W Stevenson, H L Thacker, R L Regnery.   

Abstract

Monkeypox with extensive lesions was diagnosed in a prairie dog that was involved in a recent human outbreak of monkeypox in the Midwestern United States. Gross lesions included oral ulcers, pulmonary consolidation, enlarged cervical and thoracic lymph nodes, and multifocal, small, white umbilicated plaques in the gastrointestinal wall. Microscopic lesions were extensive in the lungs and consisted of fibrinonecrotic bronchopneumonia with vasculitis and poorly defined eosinophilic intracytoplasmic inclusion bodies in cells thought to be alveolar epithelial cells, histiocytes, and fibroblasts. Multifocal necrotizing lesions, often accompanied by myxedema, were also present in most of the other examined organs. Aggregates of pox viral particles were observed within lesions by transmission electron microscopy. Monkeypox virus infection was confirmed by real-time polymerase chain reaction and virus culture at the Centers for Disease Control and Prevention. This report highlights the difficulties of rapid diagnosis of exotic or emerging diseases and further substantiates the prairie dog as an animal model of monkeypox.

Entities:  

Mesh:

Year:  2004        PMID: 15557083     DOI: 10.1354/vp.41-6-702

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  11 in total

1.  Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.

Authors:  M S Keckler; D S Carroll; N F Gallardo-Romero; R R Lash; J S Salzer; S L Weiss; N Patel; C J Clemmons; S K Smith; C L Hutson; K L Karem; I K Damon
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012.

Authors:  Scott Parker; R Mark Buller
Journal:  Future Virol       Date:  2013-02-01       Impact factor: 1.831

3.  Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

Authors:  Alvin L Smith; Marisa St Claire; Srikanth Yellayi; Laura Bollinger; Peter B Jahrling; Jason Paragas; Joseph E Blaney; Reed F Johnson
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

Review 4.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni).

Authors:  Patricia L Earl; Jeffrey L Americo; Catherine A Cotter; Bernard Moss
Journal:  Virology       Date:  2014-12-02       Impact factor: 3.616

6.  Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models.

Authors:  Jeffrey L Americo; Bernard Moss; Patricia L Earl
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

7.  Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response.

Authors:  Patricia L Earl; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

8.  Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus.

Authors:  Denise A Schultz; John E Sagartz; David L Huso; R Mark L Buller
Journal:  Virology       Date:  2008-11-01       Impact factor: 3.616

9.  A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.

Authors:  Jennifer Stabenow; R Mark Buller; Jill Schriewer; Cheri West; John E Sagartz; Scott Parker
Journal:  J Virol       Date:  2010-02-03       Impact factor: 6.549

Review 10.  Zoonotic Poxviruses Associated with Companion Animals.

Authors:  Danielle M Tack; Mary G Reynolds
Journal:  Animals (Basel)       Date:  2011-11-17       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.